Cargando…

One Step Nucleic Acid Amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas

BACKGROUND: Accurate histopathological evaluation of resected lymph nodes (LN) is essential for the reliable staging of colorectal carcinomas (CRC). With conventional sectioning and staining techniques usually only parts of the LN are examined which might lead to incorrect tumor staging. A molecular...

Descripción completa

Detalles Bibliográficos
Autores principales: Croner, Roland S, Schellerer, Vera, Demund, Helene, Schildberg, Claus, Papadopulos, Thomas, Naschberger, Elisabeth, Stürzl, Michael, Matzel, Klaus E, Hohenberger, Werner, Schlabrakowski, Anne
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944157/
https://www.ncbi.nlm.nih.gov/pubmed/20819209
http://dx.doi.org/10.1186/1479-5876-8-83
_version_ 1782187084211027968
author Croner, Roland S
Schellerer, Vera
Demund, Helene
Schildberg, Claus
Papadopulos, Thomas
Naschberger, Elisabeth
Stürzl, Michael
Matzel, Klaus E
Hohenberger, Werner
Schlabrakowski, Anne
author_facet Croner, Roland S
Schellerer, Vera
Demund, Helene
Schildberg, Claus
Papadopulos, Thomas
Naschberger, Elisabeth
Stürzl, Michael
Matzel, Klaus E
Hohenberger, Werner
Schlabrakowski, Anne
author_sort Croner, Roland S
collection PubMed
description BACKGROUND: Accurate histopathological evaluation of resected lymph nodes (LN) is essential for the reliable staging of colorectal carcinomas (CRC). With conventional sectioning and staining techniques usually only parts of the LN are examined which might lead to incorrect tumor staging. A molecular method called OSNA (One Step Nucleic Acid Amplification) may be suitable to determine the metastatic status of the complete LN and therefore improve staging. METHODS: OSNA is based on a short homogenisation step and subsequent automated amplification of cytokeratin 19 (CK19) mRNA directly from the sample lysate, with result available in 30-40 minutes. In this study 184 frozen LN from 184 patients with CRC were investigated by both OSNA and histology (Haematoxylin & Eosin staining and CK19 immunohistochemistry), with half of the LN used for each method. Samples with discordant results were further analysed by RT-PCR for CK19 and carcinoembryonic antigen (CEA). RESULTS: The concordance rate between histology and OSNA was 95.7%. Three LN were histology+/OSNA- and 5 LN histology-/OSNA+. RT-PCR supported the OSNA result in 3 discordant cases, suggesting that metastases were exclusively located in either the tissue analysed by OSNA or the tissue used for histology. If these samples were excluded the concordance was 97.2%, the sensitivity 94.9%, and the specificity 97.9%. Three patients (3%) staged as UICC I or II by routine histopathology were upstaged as LN positive by OSNA. One of these patients developed distant metastases (DMS) during follow up. CONCLUSION: OSNA is a new and reliable method for molecular staging of lymphatic metastases in CRC and enables the examination of whole LN. It can be applied as a rapid diagnostic tool to estimate tumour involvement in LN during the staging of CRC.
format Text
id pubmed-2944157
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29441572010-09-24 One Step Nucleic Acid Amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas Croner, Roland S Schellerer, Vera Demund, Helene Schildberg, Claus Papadopulos, Thomas Naschberger, Elisabeth Stürzl, Michael Matzel, Klaus E Hohenberger, Werner Schlabrakowski, Anne J Transl Med Methodology BACKGROUND: Accurate histopathological evaluation of resected lymph nodes (LN) is essential for the reliable staging of colorectal carcinomas (CRC). With conventional sectioning and staining techniques usually only parts of the LN are examined which might lead to incorrect tumor staging. A molecular method called OSNA (One Step Nucleic Acid Amplification) may be suitable to determine the metastatic status of the complete LN and therefore improve staging. METHODS: OSNA is based on a short homogenisation step and subsequent automated amplification of cytokeratin 19 (CK19) mRNA directly from the sample lysate, with result available in 30-40 minutes. In this study 184 frozen LN from 184 patients with CRC were investigated by both OSNA and histology (Haematoxylin & Eosin staining and CK19 immunohistochemistry), with half of the LN used for each method. Samples with discordant results were further analysed by RT-PCR for CK19 and carcinoembryonic antigen (CEA). RESULTS: The concordance rate between histology and OSNA was 95.7%. Three LN were histology+/OSNA- and 5 LN histology-/OSNA+. RT-PCR supported the OSNA result in 3 discordant cases, suggesting that metastases were exclusively located in either the tissue analysed by OSNA or the tissue used for histology. If these samples were excluded the concordance was 97.2%, the sensitivity 94.9%, and the specificity 97.9%. Three patients (3%) staged as UICC I or II by routine histopathology were upstaged as LN positive by OSNA. One of these patients developed distant metastases (DMS) during follow up. CONCLUSION: OSNA is a new and reliable method for molecular staging of lymphatic metastases in CRC and enables the examination of whole LN. It can be applied as a rapid diagnostic tool to estimate tumour involvement in LN during the staging of CRC. BioMed Central 2010-09-06 /pmc/articles/PMC2944157/ /pubmed/20819209 http://dx.doi.org/10.1186/1479-5876-8-83 Text en Copyright ©2010 Croner et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Methodology
Croner, Roland S
Schellerer, Vera
Demund, Helene
Schildberg, Claus
Papadopulos, Thomas
Naschberger, Elisabeth
Stürzl, Michael
Matzel, Klaus E
Hohenberger, Werner
Schlabrakowski, Anne
One Step Nucleic Acid Amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas
title One Step Nucleic Acid Amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas
title_full One Step Nucleic Acid Amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas
title_fullStr One Step Nucleic Acid Amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas
title_full_unstemmed One Step Nucleic Acid Amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas
title_short One Step Nucleic Acid Amplification (OSNA) - a new method for lymph node staging in colorectal carcinomas
title_sort one step nucleic acid amplification (osna) - a new method for lymph node staging in colorectal carcinomas
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2944157/
https://www.ncbi.nlm.nih.gov/pubmed/20819209
http://dx.doi.org/10.1186/1479-5876-8-83
work_keys_str_mv AT cronerrolands onestepnucleicacidamplificationosnaanewmethodforlymphnodestagingincolorectalcarcinomas
AT schellerervera onestepnucleicacidamplificationosnaanewmethodforlymphnodestagingincolorectalcarcinomas
AT demundhelene onestepnucleicacidamplificationosnaanewmethodforlymphnodestagingincolorectalcarcinomas
AT schildbergclaus onestepnucleicacidamplificationosnaanewmethodforlymphnodestagingincolorectalcarcinomas
AT papadopulosthomas onestepnucleicacidamplificationosnaanewmethodforlymphnodestagingincolorectalcarcinomas
AT naschbergerelisabeth onestepnucleicacidamplificationosnaanewmethodforlymphnodestagingincolorectalcarcinomas
AT sturzlmichael onestepnucleicacidamplificationosnaanewmethodforlymphnodestagingincolorectalcarcinomas
AT matzelklause onestepnucleicacidamplificationosnaanewmethodforlymphnodestagingincolorectalcarcinomas
AT hohenbergerwerner onestepnucleicacidamplificationosnaanewmethodforlymphnodestagingincolorectalcarcinomas
AT schlabrakowskianne onestepnucleicacidamplificationosnaanewmethodforlymphnodestagingincolorectalcarcinomas